157 related articles for article (PubMed ID: 30334451)
1. miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R.
Jiang T; Chen J; Huang XB; Li YX; Zhong L
Neoplasma; 2018 Nov; 65(6):907-914. PubMed ID: 30334451
[TBL] [Abstract][Full Text] [Related]
2. miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells.
Xu L; Yao Y; Lu T; Jiang L
J Musculoskelet Neuronal Interact; 2022 Jun; 22(2):251-260. PubMed ID: 35642704
[TBL] [Abstract][Full Text] [Related]
3. miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma.
Zhong L; Xu Z; Jin X; He Y; Zhang J; Jiang T; Chen J
Oncol Lett; 2020 Dec; 20(6):339. PubMed ID: 33123250
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
5. The autophagy induced by curcumin via MEK/ERK pathway plays an early anti-leukemia role in human Philadelphia chromosome-positive acute lymphoblastic leukemia SUP-B15 cells.
Guo Y; Shan QQ; Gong PY; Wang SC
J Cancer Res Ther; 2018; 14(Supplement):S125-S131. PubMed ID: 29578162
[TBL] [Abstract][Full Text] [Related]
6. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
8. The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
Rafiei A; Mian AA; Döring C; Metodieva A; Oancea C; Thalheimer FB; Hansmann ML; Ottmann OG; Ruthardt M
PLoS Genet; 2015 Apr; 11(4):e1005144. PubMed ID: 25919613
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
10. Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190
Qin R; Wang T; He W; Wei W; Liu S; Gao M; Huang Z
Cell Commun Signal; 2023 Jan; 21(1):27. PubMed ID: 36721266
[TBL] [Abstract][Full Text] [Related]
11. Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN.
Wang WZ; Lin XH; Pu QH; Liu MY; Li L; Wu LR; Wu QQ; Mao JW; Zhu JY; Jin XB
Biochem Biophys Res Commun; 2014 Nov; 454(3):423-8. PubMed ID: 25451263
[TBL] [Abstract][Full Text] [Related]
12. [Anti-leukemia effect of oridonin on Ph(+) acute lymphoblastic leukemia cell SUP-B15].
Guo Y; Shan QQ; Gong YP; Lin J; Yang X; Zhou RQ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):439-43. PubMed ID: 22967375
[TBL] [Abstract][Full Text] [Related]
13. miR-34b Alleviates High Glucose-Induced Inflammation and Apoptosis in Human HK-2 Cells via IL-6R/JAK2/STAT3 Signaling Pathway.
Lv N; Li C; Liu X; Qi C; Wang Z
Med Sci Monit; 2019 Oct; 25():8142-8151. PubMed ID: 31665127
[TBL] [Abstract][Full Text] [Related]
14. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.
Scherr M; Elder A; Battmer K; Barzan D; Bomken S; Ricke-Hoch M; Schröder A; Venturini L; Blair HJ; Vormoor J; Ottmann O; Ganser A; Pich A; Hilfiker-Kleiner D; Heidenreich O; Eder M
Leukemia; 2014 Mar; 28(3):554-65. PubMed ID: 24280866
[TBL] [Abstract][Full Text] [Related]
16. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
17. [Overexpression of miR-30a Promotes Apoptosis of Leukemia K562 Cells].
Xu M; Gao WW; Luo YJ; Wang Y; Tao K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):396-402. PubMed ID: 30998144
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
19. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hermans A; Gow J; Selleri L; von Lindern M; Hagemeijer A; Wiedemann LM; Grosveld G
Leukemia; 1988 Oct; 2(10):628-33. PubMed ID: 3172839
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation.
Okabe S; Tauchi T; Ohyashiki K
Exp Hematol; 2010 Sep; 38(9):765-72. PubMed ID: 20471447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
